Research on Llama Antibodies for Disease Diagnosis and Treatment

other · National Research Council Canada, Ottawa

Research by the National Research Council Canada and collaborators is exploring the use of llama-derived single-domain antibodies (nanobodies) for diagnosing and treating diseases such as Alzheimer's. These antibodies can cross the blood-brain barrier and specifically mark cerebral lesions. Human trials are expected to begin in the next few years.

Sources

• “Current research being conducted by Dr. Jamshid Tanha's antibody therapeutics group at the National Research Council Canada... Human trials using llama antibodies in Alzheimer's patients are predicted to get underway in the next few years.” — The Islands Grapevine – January 18th, 2024 (January 18th, 2024)

Compiled from public community sources; we report the subject under discussion, not opinion. Report a correction.